Correspondence Activity Detail
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) (CIK 0001757499) (SHPH)
Activity window: Nov. 12, 2025 to Nov. 11, 2026
Export this company’s current score, component values, matched signals, and scoring date as a one-row CSV snapshot.
Probe Score Breakdown
The total combines correspondence volume, AI sentiment, matched keywords and signals, and a weighted
8-K adjustment, capped at 10.0. This is the 365-day
v1 snapshot. Computed:
Oct. 24, 2026.
Latest filing activity:
Feb. 13, 2026.
These dates describe different events.
Matched Signals
No stored keyword or signal matches were recorded for this activity window.
Filings In This Window
| Date | Form | Sentiment | Urgency | Summary | Open |
| Feb. 13, 2026 |
CORRESP |
Neutral/Informational |
Moderate |
The correspondence from E.F. Hutton & Co. to the SEC requests the acceleration of the effectiveness of Shuttle Pharmaceuticals Holdings, Inc.'s Registration Statement on Form S-1.… |
Read Filing
EDGAR
|
| Feb. 13, 2026 |
CORRESP |
Neutral/Informational |
Moderate |
Shuttle Pharmaceuticals Holdings, Inc. has submitted a request to the SEC for the acceleration of the effectiveness of its Registration Statement No. 333-293363 on Form S-1. The c… |
Read Filing
EDGAR
|
| Jan. 29, 2026 |
CORRESP |
Neutral/Informational |
Moderate |
Shuttle Pharmaceuticals Holdings, Inc. has submitted a request to the SEC for the acceleration of the effectiveness of its Registration Statement No. 333-291628 on Form S-1. The c… |
Read Filing
EDGAR
|
| Jan. 20, 2026 |
CORRESP |
Neutral/Informational |
Low |
Shuttle Pharmaceuticals Holdings, Inc. has responded to the SEC's comments regarding their Amendment No. 1 to the Registration Statement on Form S-1. The SEC sought clarification … |
Read Filing
EDGAR
|
| Jan. 16, 2026 |
UPLOAD |
Concern from SEC |
Moderate |
The SEC has reviewed Shuttle Pharmaceuticals Holdings, Inc.'s response to a previous comment letter regarding their Registration Statement on Form S-1. They have issued a follow-u… |
Read Filing
EDGAR
|
| Dec. 29, 2025 |
CORRESP |
Concern from SEC |
Moderate |
Shuttle Pharmaceuticals Holdings, Inc. responded to the SEC's inquiry regarding their Amendment No. 1 to the Registration Statement on Form S-1, specifically addressing the acquis… |
Read Filing
EDGAR
|
| Dec. 15, 2025 |
UPLOAD |
Concern from SEC |
Moderate |
The SEC has conducted a limited review of Shuttle Pharmaceuticals Holdings, Inc.'s registration statement and has requested additional information regarding the acquisition of Mol… |
Read Filing
EDGAR
|
Notable 8-Ks In This Window
No notable 8-Ks were stored for this company in this activity window.